Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients

(2020) Andreas Schäfer et al.   CARDIOVASCULAR DRUGS AND THERAPY

Conduct and reporting of individual participant data network meta-analyses need improvement

(2020) Anna Chaimani   BMC Medicine

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Edoxaban versus Warfarin in Patients with Atrial Fibrillation at the Extremes of Body Weight: An Analysis from the ENGAGE AF-TIMI 48 Trial

(2020) Giuseppe Boriani et al.   THROMBOSIS AND HAEMOSTASIS

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

(2020) Anthony P Carnicelli et al.   AMERICAN HEART JOURNAL

2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

(2019) Craig T. January et al.   CIRCULATION

Effectiveness and Safety of Direct Oral Anticoagulants versus Vitamin K Antagonists for People Aged 75 Years and over with Atrial Fibrillation: A Systematic Review and Meta-Analyses of Observational Studies

(2019) Anneka Mitchell et al.   Journal of Clinical Medicine

Effects of dabigatran according to age in atrial fibrillation

(2017) Mandy N Lauw et al.   HEART

Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation

(2016) Freddy Del-Carpio Munoz et al.   AMERICAN JOURNAL OF CARDIOLOGY

Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with atrial fibrillation†

(2015) Michelle L. O'Donoghue et al.   EUROPEAN HEART JOURNAL

Incorporation of individual-patient data in network meta-analysis for multiple continuous endpoints, with application to diabetes treatment

(2015) Hwanhee Hong et al.   STATISTICS IN MEDICINE

Organ-specific bleeding patterns of anticoagulant therapy: lessons from clinical trials

(2014) Thomas Vanassche et al.   THROMBOSIS AND HAEMOSTASIS

Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: Results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial

(2013) David A. Garcia et al.   AMERICAN HEART JOURNAL

Clinical Outcomes With Rivaroxaban in Patients Transitioned From Vitamin K Antagonist Therapy

(2013) Kenneth W. Mahaffey et al.   ANNALS OF INTERNAL MEDICINE

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies

(2013) Jay Desai et al.   THROMBOSIS AND HAEMOSTASIS

Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation

(2011) John W. Eikelboom et al.   CIRCULATION

Apixaban versus Warfarin in Patients with Atrial Fibrillation

(2011) Christopher B. Granger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

(2011) Manesh R. Patel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dabigatran and Warfarin in Vitamin K Antagonist–Naive and –Experienced Cohorts With Atrial Fibrillation

(2010) Michael D. Ezekowitz et al.   CIRCULATION

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE